Details for New Drug Application (NDA): 214375
✉ Email this page to a colleague
The generic ingredient in XENOVIEW is xenon xe-129 hyperpolarized. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the xenon xe-129 hyperpolarized profile page.
Summary for 214375
| Tradename: | XENOVIEW |
| Applicant: | Polarean |
| Ingredient: | xenon xe-129 hyperpolarized |
| Patents: | 2 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 214375
Generic Entry Date for 214375*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
GAS;INHALATION |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 214375
| Mechanism of Action | Magnetic Resonance Contrast Activity |
Suppliers and Packaging for NDA: 214375
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375 | NDA | Polarean, Inc. | 80534-0300 | 80534-0300-1 | 50 BAG in 1 CARTON (80534-0300-1) / 300 mL in 1 BAG |
| XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375 | NDA | Polarean, Inc. | 80534-0500 | 80534-0500-1 | 50 BAG in 1 CARTON (80534-0500-1) / 500 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GAS;INHALATION | Strength | N/A | ||||
| Approval Date: | Dec 23, 2022 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | Dec 23, 2027 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Feb 20, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Dec 29, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
